Literature DB >> 3286537

Two-day cefamandole versus five-day cephazolin prophylaxis in 965 total hip replacements. Report of a multicentre double blind randomised trial.

J Evrard1, F Doyon, J F Acar, J C Salord, F Mazas, R Flamant.   

Abstract

The aim of this trial was to compare a 5-day course of cephazolin with a regimen of 2 days of cefamandole in 965 total hip replacements (488 in the cefamandole group and 477 in the cephazolin group). The effect of the prophylactic antibiotic on the bacterial colonization of drains (mean duration of drainage: 3.2 +/- 0.3 days) and on the susceptibility of colonizing organisms was assessed. No significant difference was observed in the percentage of infected drains between the two groups. The cefamandole group had a lower rate of Gram-negative organisms (23% versus 44%, p less than 0.01). The rate of deep infections within one year after operation was 0.7% in the cefamandole group versus 0.5% in the cephazolin group, and the difference is not significant. Cefamandole given for two days appears to be an effective prophylaxis against sepsis in total hip replacements.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3286537     DOI: 10.1007/bf00265744

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  21 in total

1.  BL-S786, a new parenteral cephalosporin. II. In vitro antimicrobial activity comparison with six related cephalosporins.

Authors:  R N Jones; C Thornsberry; A L Barry; P C Fuchs; T L Gavin; E H Gerlach
Journal:  J Antibiot (Tokyo)       Date:  1977-07       Impact factor: 2.649

2.  Activity of cefamandole and other cephalosporins against aerobic and anaerobic bacteria.

Authors:  E C Ernst; S Berger; M Barza; N V Jacobus; F P Tally
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

3.  Prophylactic cefamandole in orthopaedic surgery.

Authors:  J M Gatell; J Riba; M L Lozano; J Maña; R Ramon; J García SanMiguel
Journal:  J Bone Joint Surg Am       Date:  1984-10       Impact factor: 5.284

4.  Prophylactic and preventive antibiotic therapy: timing, duration and economics.

Authors:  H H Stone; B B Haney; L D Kolb; C E Geheber; C A Hooper
Journal:  Ann Surg       Date:  1979-06       Impact factor: 12.969

5.  In vitro studies of cefamandole.

Authors:  G P Bodey; S Weaver
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

6.  Cephalothin and cefamandole penetration into bone, synovial fluid, and wound drainage fluid.

Authors:  D J Schurman; H P Hirshman; D S Burton
Journal:  J Bone Joint Surg Am       Date:  1980-09       Impact factor: 5.284

7.  ["In vitro" activity of cefamandole, cefalotin, cefoxitin and cefuroxim against enterobacteria and Staphylococcus aureus isolated in hospital (author's transl)].

Authors:  A Thabaut; J L Durosoir; P Saliou
Journal:  Pathol Biol (Paris)       Date:  1979-12

8.  Cephalosporin prophylaxis for total hip replacement.

Authors:  M A Ritter; M F Conway; E A Stringer; J G Williams
Journal:  Orthopedics       Date:  1983-07-01       Impact factor: 1.390

9.  The effect of the combined use of a clean air system and one day prophylactic administration of cefamandole in total hip replacement.

Authors:  J C Mulier; N Cheng; B Van Tornout; J Vandepitte; H Debruyne
Journal:  Arch Orthop Trauma Surg       Date:  1981

10.  Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cephalexin.

Authors:  S Eykyn; C Jenkins; A King; I Phillips
Journal:  Antimicrob Agents Chemother       Date:  1973-06       Impact factor: 5.191

View more
  8 in total

1.  Regional prophylaxis with teicoplanin in monolateral or bilateral total knee replacement: an open study.

Authors:  F de Lalla; R Viola; G Pellizzer; L Lazzarini; A Tramarin; P Fabris
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

2.  [Results before and after introduction of perioperative antibiotic prophylaxis in hip joint prostheses treatment of geriatric patients].

Authors:  W Kaiser; V Gulielmos; H Hausmann; S Ghalehasadi
Journal:  Unfallchirurgie       Date:  1996-08

Review 3.  Antibiotic prophylaxis for surgery for proximal femoral and other closed long bone fractures.

Authors:  William J Gillespie; Geert Him Walenkamp
Journal:  Cochrane Database Syst Rev       Date:  2010-03-17

Review 4.  Methicillin-resistant staphylococci in clean surgery. Is there a role for prophylaxis?

Authors:  E Mini; S Nobili; P Periti
Journal:  Drugs       Date:  1997       Impact factor: 9.546

Review 5.  Fluoroquinolones and surgical prophylaxis.

Authors:  P Dellamonica; E Bernard
Journal:  Drugs       Date:  1993       Impact factor: 9.546

6.  Infection in massive bone allografts sterilised by radiation.

Authors:  B Loty; B Tomeno; J Evrard; M Postel
Journal:  Int Orthop       Date:  1994-06       Impact factor: 3.075

Review 7.  Systematic review and meta-analysis of randomized controlled trials of antibiotics and antiseptics for preventing infection in people receiving primary total hip and knee prostheses.

Authors:  Jeffrey Voigt; Michael Mosier; Rabih Darouiche
Journal:  Antimicrob Agents Chemother       Date:  2015-08-10       Impact factor: 5.191

Review 8.  Antibiotics and antiseptics for preventing infection in people receiving revision total hip and knee prostheses: a systematic review of randomized controlled trials.

Authors:  Jeffrey Voigt; Michael Mosier; Rabih Darouiche
Journal:  BMC Infect Dis       Date:  2016-12-12       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.